Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

31.34 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Long Island University and Omnicell Launch Center for Innovative Medication Management
From Omnicell, Inc.
Via Business Wire
Omnicell to Release First Quarter 2023 Financial Results on May 2, 2023
From Omnicell, Inc.
Via Business Wire
Analyst Expectations for Omnicell's Future
 
Via Benzinga
Omnicell Announces Fiscal Year and Fourth Quarter 2022 Results
From Omnicell, Inc.
Via Business Wire
Earnings Preview For Omnicell
 
Via Benzinga
6 Analysts Have This to Say About Omnicell
 
Via Benzinga
Why Shares of Omnicell Dropped 33.6% This Week
The healthcare medication management company released lowered guidance. 
Via The Motley Fool
Where Omnicell Stands With Analysts
Omnicell (NASDAQ:OMCL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023
 
Via Benzinga
CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
From Omnicell, Inc.
Via Business Wire
Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday
Citigroup raised the price target for AT&T Inc. (NYSE: T) from $20 to $22. Citigroup analyst Michael Rollins maintained a Buy rating. AT&T shares fell 1% to $18.91 in pre-market trading. 
Via Benzinga
Omnicell to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Omnicell, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
From Omnicell, Inc.
Via Business Wire
Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference
From Omnicell, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
Upgrades 
Via Benzinga
9 Analysts Have This to Say About Omnicell
Over the past 3 months, 9 analysts have published their opinion on Omnicell (NASDAQ:OMCL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results. 
Via Benzinga
Rogers, Airbnb, Herbalife And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded lower, with the Nasdaq Composite dropping more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Omnicell: Q3 Earnings Insights
Omnicell (NASDAQ:OMCL) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Omnicell beat estimated earnings... 
Via Benzinga
Omnicell Announces Financial Results for Third Quarter 2022
From Omnicell, Inc.
Via Business Wire
Omnicell to Release Third Quarter 2022 Financial Results on November 2, 2022
From Omnicell, Inc.
Via Business Wire
Omnicell Launches Specialty Pharmacy Services to Support Optimized Outpatient Medication Management and Drive Clinical and Business Outcomes for Health Systems
From Omnicell, Inc.
Via Business Wire
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero... 
Via Benzinga
Morgan Stanley To Rally Over 10%? Here Are 5 Other Price Target Changes For Wednesday
Credit Suisse raised the price target on Morgan Stanley (NYSE: MS) from $95 to $97. Credit Suisse analyst Susan Roth Katzke maintained the stock with an Outperform rating. Morgan Stanley shares rose... 
Via Benzinga
Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day
From Omnicell, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.